thrombopoietin receptor agonist (Ractigen Therapeutics)

N/A

Report date: 2025/01/26 17:14:04
NME

Base Information

Drug Namethrombopoietin receptor agonist (Ractigen Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionThrombopoietin receptor agonists
TargetsThrombopoietin receptor
Therapy Area/IndicationsThrombocytopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRactigen Therapeutics (Nantong) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRactigen Therapeutics (Nantong) Co Ltd
Inactive CompaniesN/A
Active IndicationsThrombocytopenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A